426 related articles for article (PubMed ID: 18408141)
1. Identification of proteins secreted from leptin stimulated MCF-7 breast cancer cells: a dual proteomic approach.
Perera CN; Spalding HS; Mohammed SI; Camarillo IG
Exp Biol Med (Maywood); 2008 Jun; 233(6):708-20. PubMed ID: 18408141
[TBL] [Abstract][Full Text] [Related]
2. Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression.
Perera CN; Chin HG; Duru N; Camarillo IG
J Endocrinol; 2008 Nov; 199(2):221-33. PubMed ID: 18715880
[TBL] [Abstract][Full Text] [Related]
3. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis reveals that 14-3-3sigma is down-regulated in human breast cancer cells.
Vercoutter-Edouart AS; Lemoine J; Le Bourhis X; Louis H; Boilly B; Nurcombe V; Révillion F; Peyrat JP; Hondermarck H
Cancer Res; 2001 Jan; 61(1):76-80. PubMed ID: 11196201
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of liver cancer cells treated with suberonylanilide hydroxamic acid.
Tong A; Zhang H; Li Z; Gou L; Wang Z; Wei H; Tang M; Liang S; Chen L; Huang C; Wei Y
Cancer Chemother Pharmacol; 2008 Apr; 61(5):791-802. PubMed ID: 17593366
[TBL] [Abstract][Full Text] [Related]
6. Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis.
Liu Y; Liu H; Han B; Zhang JT
Cancer Res; 2006 Mar; 66(6):3248-55. PubMed ID: 16540677
[TBL] [Abstract][Full Text] [Related]
7. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].
Yan XD; Pan LY
Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965
[TBL] [Abstract][Full Text] [Related]
8. Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells.
Zhang F; Zhang L; Zhang B; Wei X; Yang Y; Qi RZ; Ying G; Zhang N; Niu R
J Proteome Res; 2009 Nov; 8(11):5041-7. PubMed ID: 19764771
[TBL] [Abstract][Full Text] [Related]
9. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression.
Mauro L; Catalano S; Bossi G; Pellegrino M; Barone I; Morales S; Giordano C; Bartella V; Casaburi I; Andò S
Cancer Res; 2007 Apr; 67(7):3412-21. PubMed ID: 17409452
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of the E2F1 response in p53-negative cancer cells: new aspects in the regulation of cell survival and death.
Li Z; Kreutzer M; Mikkat S; Mise N; Glocker MO; Pützer BM
Proteomics; 2006 Nov; 6(21):5735-45. PubMed ID: 17001603
[TBL] [Abstract][Full Text] [Related]
11. Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs.
Chuthapisith S; Layfield R; Kerr ID; Hughes C; Eremin O
Int J Oncol; 2007 Jun; 30(6):1545-51. PubMed ID: 17487377
[TBL] [Abstract][Full Text] [Related]
12. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells.
Willipinski-Stapelfeldt B; Riethdorf S; Assmann V; Woelfle U; Rau T; Sauter G; Heukeshoven J; Pantel K
Clin Cancer Res; 2005 Nov; 11(22):8006-14. PubMed ID: 16299229
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of a highly metastatic gastric cancer cell line using two-dimensional differential gel electrophoresis.
Takikawa M; Akiyama Y; Maruyama K; Suzuki A; Liu F; Tai S; Ohshita C; Kawaguchi Y; Bandou E; Yonemura Y; Yamaguchi K
Oncol Rep; 2006 Oct; 16(4):705-11. PubMed ID: 16969483
[TBL] [Abstract][Full Text] [Related]
14. Analysis of secreted proteins for the study of bladder cancer cell aggressiveness.
Makridakis M; Roubelakis MG; Bitsika V; Dimuccio V; Samiotaki M; Kossida S; Panayotou G; Coleman J; Candiano G; Anagnou NP; Vlahou A
J Proteome Res; 2010 Jun; 9(6):3243-59. PubMed ID: 20423150
[TBL] [Abstract][Full Text] [Related]
15. Proteomic identification of differentially expressed proteins in curcumin-treated MCF-7 cells.
Fang HY; Chen SB; Guo DJ; Pan SY; Yu ZL
Phytomedicine; 2011 Jun; 18(8-9):697-703. PubMed ID: 21239154
[TBL] [Abstract][Full Text] [Related]
16. Expression of proteasomal proteins in ten different tumor cell lines.
Afjehi-Sadat L; Gruber-Olipitz M; Felizardo M; Slavc I; Lubec G
Amino Acids; 2004 Oct; 27(2):129-40. PubMed ID: 15455211
[TBL] [Abstract][Full Text] [Related]
17. Identification of the amyloid β-protein precursor and cystatin C as novel epidermal growth factor receptor regulated secretory proteins in nasopharyngeal carcinoma by proteomics.
Tang CE; Guan YJ; Yi B; Li XH; Liang K; Zou HY; Yi H; Li MY; Zhang PF; Li C; Peng F; Chen ZC; Yao KT; Xiao ZQ
J Proteome Res; 2010 Dec; 9(12):6101-11. PubMed ID: 20882990
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of MCF-7 breast cancer cell line exposed to mitogenic concentration of 17beta-estradiol.
Malorni L; Cacace G; Cuccurullo M; Pocsfalvi G; Chambery A; Farina A; Di Maro A; Parente A; Malorni A
Proteomics; 2006 Nov; 6(22):5973-82. PubMed ID: 17051647
[TBL] [Abstract][Full Text] [Related]
19. Alterations in the mitochondrial proteome of adriamycin resistant MCF-7 breast cancer cells.
Strong R; Nakanishi T; Ross D; Fenselau C
J Proteome Res; 2006 Sep; 5(9):2389-95. PubMed ID: 16944951
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis in human breast cancer: identification of a characteristic protein expression profile of malignant breast epithelium.
Hudelist G; Singer CF; Pischinger KI; Kaserer K; Manavi M; Kubista E; Czerwenka KF
Proteomics; 2006 Mar; 6(6):1989-2002. PubMed ID: 16470630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]